KRAS mutations predict progression of preneoplastic gastric lesions

Cancer Epidemiology Biomarkers and Prevention

Volumn 8, Issue 2, 1999, Pages 167-171

  Gong, Changning ^a   Mera, Robertino ^a   Bravo, Juan C ^a   Ruiz, Bernardo ^a   Diaz Escamilla, Rafael ^a   Fontham, Elizabeth T H ^a   Correa, Pelayo ^a   Hunt, Jay D ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; BISMUTH SALICYLATE; METRONIDAZOLE;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; CANCER PREVENTION; DENATURING GRADIENT GEL ELECTROPHORESIS; DIET SUPPLEMENTATION; FEMALE; GASTROINTESTINAL INFECTION; GENE MUTATION; HUMAN; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; PRECANCER; PREDICTION; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH CANCER; TUMOR GROWTH;

ANALYSIS OF VARIANCE; ANTIOXIDANTS; BIOPSY; CELL TRANSFORMATION, NEOPLASTIC; CHEMOPREVENTION; CODON; DIETARY SUPPLEMENTS; DISEASE PROGRESSION; DNA; EXONS; FEMALE; FOLLOW-UP STUDIES; FORECASTING; GASTRIC MUCOSA; GASTRITIS, ATROPHIC; GENES, RAS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERVENTION STUDIES; MALE; METAPLASIA; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; ODDS RATIO; POINT MUTATION; PRECANCEROUS CONDITIONS; STOMACH NEOPLASMS;

EID: 0033049746     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Gore, R. M. Gastric cancer. Clinical and pathologic features. Radiol. Clin. N. Am., 35: 295-310, 1997.
2. Cancer Facts and Figures-1997. Atlanta, GA: American Cancer Society, 1997.
3. Lauren, P. The two histologic main types of gastric carcinoma: diffuse and so-called intestinal type carcinoma. An attempt at histochemical classification. Acta Pathol. Microbiol. Scand., 64: 31-49, 1965.
4. Correa, P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res., 52: 6735-6740, 1992.
5. Solcia, E., Fiocca, R., Luinetti, O., Villani, L., Padovan, L., Calistri, D., Ranzani, G. N., Chiaravalli, A., and Capella, C. Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement. Am. J. Surg. Pathol., 20 (Suppl. 1 ): S8-S22, 1996.
6. Correa, P., and Shiao, Y-h. Phenotypic and genotypic events in gastric carcinogenesis. Cancer Res. Suppl., 54: 1941s-1943s, 1994.
7. Hiyama, E., Yokoyama, T., Tatsumoto, N., Hiyama, K., Imamura, Y., Murakami, Y., Kodama, T., Piatyszek, M. A., Shay, J. W., and Matsuura, Y. Telomerase activity in gastric cancer. Cancer Res., 55: 3258-3262, 1995.
8. Tahara, E. Molecular mechanism of stomach carcinogenesis. J. Cancer. Res. Clin. Oncol., 119: 265-272, 1993.
9. Cooper, G. M. Guanine nucleotide binding proteins. In: Oncogenes, pp. 222-242. Sudbury, MA: Jones and Bartlett Publishers, 1995.
10. Correa, P. Helicobacter pylori and gastric carcinogencsis. Am. J. Surg. Pathol., 19 (Suppl. 1). S37-S43, 1995.
11. Mannick, E. E., Bravo, L. E., Zarama, G., Realpe, J. L., Zhang, X-J., Ruiz, B., Fontham, E. T. H., Mera, R., Miller, M. J. S., and Correa, P. Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effects of antibiotics and antioxidants. Cancer Res., 56: 3238-3243, 1996.
12. Correa, P., Haenszel, W., Cuello, C., Zavala, D., Fontham, E., Zarama, G., Tannenbaum, S., Collazos, T., and Ruiz, B. Gastric precancerous process in a high risk population: cohort follow-up. Cancer Res., 50: 4737-4740, 1990.
13. Correa, P., Haenszel, W., Cuello, C., Zavala, D., Fontham, E., Zarama, G., Tannenbaum, S., Collazos, T., and Ruiz, B. Gastric precancerous process in a high risk population: cross sectional studies. Cancer Res., 50: 4731-4736, 1990.
14. Chen, V. W., Abu-Elyazeed, R. R., Zavala, D. E., Ktsanes, V. K., Haenszel, W., Cuello, C. Montes, G., and Correa, P. Risk factors of gastric precancerous lesions in a high-risk Colombian population. I. Salt. Nutr. Cancer. 13: 59-65, 1990.
15. Chen, V. W., Abu-Elyazeed, R. R., Zavala, D. E., Haenszel, W., Ktsanes, V. K., Rice, J., Cuello, C., Montes, G., and Correa, P. Risk factors of gastric precancerous lesions in a high-risk Colombian population. II. Nitrate and nitrite. Nutr. Cancer. 13: 67-72, 1990.
16. Correa, P., Muñoz, N., Cuello, C., Fox, J., Zavala, D., and Ruiz, B. The role of Campylobacter pylori in gastro-duodenal disease. In: C. Fenoglio-Preiser (ed.), Progress in Surgical Pathology, pp. 191-210. Philadelphia: Field & Wood, 1989.
17. Garvey, W., Fathi, A., and Bigelow, F. Modified Steiner for the demonstration of spirochetes. J. Histotechnol., 8: 15-17, 1985.
18. Siegfried, J. M., Gillespie, A. T., Mera, R., Casey, T. J., Keohavong, P., Testa, J. R., and Hunt, J. D. Prognostic value of specific KRAS mutations in lung adenocarcinoma. Cancer Epidemiol. Biomark. Prev., 6: 841-849, 1997.
19. Bos, J. L. ras oncogenes in human cancer: a review. Cancer Res., 49: 4682-4689, 1989.
20. Bos, J. L. The ras gene family and human carcinogenesis. Mutat. Res., 195: 255-271, 1988.
21. Rodenhuis, S. RAS oncogenes and human lung cancer. In: H. I. Pass, J. B. Mitchell, D. H. Johnson, and A. T. Turrisi (eds.), Lung Cancer: Principles and Practice, pp. 73-82. Philadelphia: Lippincott-Raven Publishers, 1996.
22. Gulbis, B., and Galand, P. Immunodetection of the p21-ras products in human normal and preneoplastic tissues and solid tumors: a review. Hum. Pathol., 24: 1271-1285, 1993.
23. Motojima, K., Furui, J., Kohara, N., Izawa, K., Kanematsu, T., and Shiku, H. Expression of Kirsten-ras p21 in gastric cancer correlates with tumor progression and is prognostic. Diagn. Mol. Pathol., 3: 184-191, 1994.
24. Pellegata, N. S., Losekoot, M., Fodde, R., Pugliese, V., Saccomanno, S., Renault. B., Bernini, L. F., and Ranzani, G. N. Detection of K-ras mutations by denaturing gradient gel electrophoresis (DGGE): a study on pancreatic cancer. Anticancer Res., 12: 1731-1735, 1992.
25. Capon, D. J., Seeburg, P. H., McGrath, J. P., Hayflick, J. S., Edman, U., Levinson, A. D., and Goeddel, D. V. Activation of Ki-ras 2 gene in human colon and lung carcinoma by two different point mutations. Nature (Lond.), 304: 507-513, 1983.